3-rx.comCustomer Support
3-rx.com
   
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics



\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>


Join our Mailing List





Syndicate

You are here : 3-RX.com > Home > Diabetes -

Expert Available To Discuss Recent Diabetes Study

DiabetesFeb 15, 08

Last week it was reported that the National Institutes of Health abruptly halted part of a major study on diabetes and heart disease following an unexpected number deaths among patient enrollees. The study, which aimed at reducing blood sugar to normal levels in type 2 diabetics. The study included patients that were at especially high risk of heart attack and stroke, resulting in 257 deaths (as compared with 203 in the standard treatment group). Perhaps more alarming than the number of reported deaths: the NIH’s National Heart Lung and Blood Institute stressed they were unable to link the increased number of deaths in the survey to any drug, including Avandia.

“It is imperative for diabetic patients to take their condition seriously when it comes to controlling their glucose levels,” says Richard M. Goldfarb, MD and medical director of the Buck County Clinical Research Center. “Everyone knows a diabetic or has diabetic brother, boyfriend, uncle, or mother who eats that piece of chocolate cake first and pops a pill second.

The tragic derailment of the NIH study serves as a wake-up call. The aborted study not only underscores the seriousness of diabetics adhering to their medication regimens but the importance of patients better monitoring their dietary intake. More and more, that includes adding natural nutritional supplements to their diets.”

One of nutritional supplements studied at the Bucks County Clinical Research Center is based upon the principle that cinnamon can help regulate glucose levels. Cinnergen™, a non-prescription liquid whole food nutritional supplement promotes healthy glucose metabolism and is clinically proven to decrease the symptoms that commonly accompany elevated blood sugar. Upon completion of a randomized, double blind, Phase I clinical study to determine the efficacy of Cinnergen, results showed a positive effect on its ability to lower blood sugar in Type II diabetes. During the clinical study, 48% of patients using Cinnergen experienced a decrease in their blood sugar in the first seven days with an average drop of 12%. At the completion of the study, 52% of patients using Cinnergen displayed a decrease in their overall blood sugar level with an average drop of 17%.

February 25th is American Diabetes Alert Day: for those covering health news, eFoodSafety offers as an expert commentator Dr. Richard Goldfarb.

Biography on Expert
Dr. Richard M. Goldfarb was awarded a distinguished honor of academic excellence by becoming a Fellow in the American College of Surgeons, after completing his board certification in Surgery. Dr. Goldfarb received his BA from George Washington University. He then proceeded to medical school, graduating with honors from University of Health Sciences/Chicago Medical School. In addition to practicing clinical surgery for over twenty years, he serves as Medical Director for Bucks County Clinical Research, an FDA-approved facility, performing human clinical trials for several major pharmaceutical and nutritional companies worldwide. Dr. Goldfarb continues to clinically study new and innovative products and brings a wealth of knowledge to the board of directors of eFoodSafety.com, Inc. through his extensive medical and business background.

Dr. Goldfarb serves as an expert resource on the following:

• Diabetes awareness
• National Institutes of Health recent diabetes study
• Nutritional supplements

Dr. Goldfarb can address the following FAQs:

• What are some of the broader medical ramifications of the recently aborted National Institutes of Health diabetes study?
• How might our nutrition choices help regulate glucose regulation?
• What are some helpful day-to-day health tips for Type II diabetics?

About eFoodSafety.com
eFoodSafety.com, Inc. is dedicated to improving health conditions around the world through its innovative technologies. The company is the owner of Cinnergen™, a clinically-studied, non-prescription liquid whole food nutritional supplement that promotes healthy glucose metabolism available for sale at (www. cinnergen.com) and through national retailers; and Cinnechol™, a multi-faceted nutritional supplement specifically designed to naturally reduce total cholesterol levels without causing any side effects.

Source: efoodsafety



Print Version
Tell-a-Friend
comments powered by Disqus

RELATED ARTICLES:
  Implantable ‘artificial pancreas’ could help diabetes patients control their blood sugar
  Joslin researchers find drugs are effective for diabetic macular edema in new trial
  New superfoods could help key protein keep bodies healthy
  Poor quality of life may affect teens’ diabetes management
  Cancer drug protects against diabetes
  Amino acid’s increase is suspected in diabetes
  New Type 2 Diabetes Drug Onglyza Approved
  Mail order pharmacy use safe for people with diabetes
  Policy considerations pose options for leaders to reduce costly disparities in diabetes
  Cedars-Sinai study sheds light on bone marrow stem cell therapy for pancreatic recovery
  Obesity-Linked Diabetes in Children Resists Treatment
  Diabetes again linked to colon cancer risk

 












Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site